Legal Disclaimer

The material on this website was prepared exclusively for information and discussion purposes, and is not meant to be, nor shall it be construed as, an attempt to define all terms and conditions of any transaction or to contain all information that is, or may be, material to an investor. Neither Valence Advantage Life Sciences Fund II (“Valence Advantage”), Caxton Associates LP (“Caxton”) nor Caxton Advantage Venture Partners, L.P. ("CAVP") nor their respective principals or affiliates are soliciting any action based upon this material, and this material is not meant to be, nor shall-it be construed as, an offer or solicitation of an offer for the purchase or sale of any security or advisory or other service. If, in the future, any security or service is offered or sold, such offer or sale shall occur only pursuant to, and a decision to invest therein should be made solely on the basis of, a definitive offering circular, and shall be made exclusively to qualified investors in a private offering exempt from registration under all applicable securities and other laws. Any such offering circular shall contain material information not contained herein, and shall supplement, amend, and/or supersede in its entirety the information referred to herein. All information contained herein is subject to change without notice.